BE study design issue [Design Issues]

posted by Dr_Dan  – Germany, 2019-12-18 15:04 (767 d 21:07 ago) – Posting: # 20992
Views: 2,525

Hi John
if the recommended dosage regimen of the IR as per product monograph IR is to be given every 4 hrs then this means that higher doses have either a safety issue or the dose/effect relationship is in disfavor of higher doses. In this case AUC alone does not matter. Consequently, a regulatory body will reject the study
Hope this helps
KR
Dr_Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

Activity
 Admin contact
21,848 posts in 4,572 threads, 1,555 registered users;
online 7 (1 registered, 6 guests [including 2 identified bots]).
Forum time: Monday 12:12 CET (Europe/Vienna)

Do, or do not.
There is no ‘try’.    Yoda

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5